Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI

Clinical trial NCT05160714 · UNKNOWN

Trial details

NCT number: NCT05160714
Sponsor: University Hospital Tuebingen
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2022-01-01
Primary completion: 2023-03-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.